Pharscin Pharma
00290712.762.41% ( +0.30 )
Pharscin Pharma (002907)
Chongqing Pharscin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China and in...
- Open
- 12.43
- High
- 12.80
- Low
- 12.43
- Prev. Close
- 12.46
- Volume
- 44.45K
- Turnover
- 56.42M
- Avg Price
- 12.69
- Bid/Ask Ratio
- --
- Amplitude
- 2.97%
- 52wk High
- 21.45
- Volume Ratio
- 0.44
- Turnover Ratio
- 1.06%
News
- Zhitong · Oct 29, 2025 at 03:06 AM
Pharscin Pharma: Injectable Sulbactam-Nafcillin has received drug re-registration approval
- Zhitong · Oct 28, 2025 at 05:19 AM
Pharscin Pharma released its performance for the first three quarters, with a net profit attributable to the parent company of 72.4556 million yuan, a year-on-year decrease of 2.84%
- Zhitong · Oct 23, 2025 at 03:26 AM
Pharscin Pharma: Crizotinib capsules are expected to be launched for sale by the end of next year
- Zhitong · Oct 20, 2025 at 04:43 AM
Pharscin Pharma obtained the drug registration certificate for Crizotinib capsules
- Zhitong · Oct 14, 2025 at 08:33 AM
Pharscin Pharma's controlling shareholder's concerted action parties plan to reduce their holdings by no more than 3%
- Zhitong · Sep 29, 2025 at 04:14 AM
Pharscin Pharma: The company has received the drug re-registration approval notice
